Diabetes

BAGSVÆRD, Denmark — The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

Novo Nordisk said it received complete response letters from the FDA for Tresiba (insulin degludec) and Ryzodeg (insulin degludec and insulin aspart). The FDA issues a complete response letter when it has finished reviewing an application for a drug, but determines that the application can't be approved in its current form.

PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

SILVER SPRING, Md. - The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

The FDA approved Macleods' pioglitazone hydrochloride tablets in the 15 mg, 30 mg and 45 mg strengths.

The drug is a generic version of Takeda's Actos, branded and generic versions of which had sales of about $2.7 billion during the 12-month period that ended in August 2012, according to IMS Health.

BENTONVILLE, Ark. — Sam's Club will offer free heart health screenings at 563 of its stores on Saturday, the club retailer said.

The screenings, taking place at stores with pharmacies, will include tests valued at up to $100 for glucose, total cholesterol, high-density lipoprotein cholesterol, blood pressure, body mass index and vision screenings.

INDIANAPOLIS — Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's Accu-Chek products compared with other blood-glucose-meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study released Tuesday. 

The study gathered responses from 2,681 current meter users with type 1 and 2 diabetes in the U.S. to determine customer satisfaction across six factors: performance; ease of use; design; features; cost of test strips; and training.

ARLINGTON, Va. — A university research project to look at the potential effects on patient health of incorporating medication management strategies into existing care teams has won a grant from the National Association of Chain Drug Stores' philanthropic arm.

The NACDS Foundation said it gave the University of Nebraska Medical Center one of three research grants for the project, which will look at the effects of the strategies when they're incorporated into teams such as medical homes and accountable care organizations.

A new study conducted by researchers at the University of Minnesota and nearby healthcare institutions shows that patients with diabetes experience better outcomes when they undergo face-to-face medication therapy management sessions with pharmacists.

ARLINGTON, Va. — Face-to-face medication therapy management services can improve health outcomes for patients with diabetes, according to a new study.